peptide t has been researched along with Bone Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, J; Chen, X; Gu, Y; Huang, S; Wang, H; Wu, X; Xu, Y; Zhang, H; Zhang, Y | 1 |
Baamonde, A; Hidalgo, A; Lastra, A; Meana, Á; Menéndez, L; Pevida, M | 1 |
2 other study(ies) available for peptide t and Bone Neoplasms
Article | Year |
---|---|
Study on the cellular internalization mechanisms and
Topics: Animals; Arginine; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cysteine; Genetic Vectors; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Peptide Fragments; Peptide T; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden | 2020 |
The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Topics: Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Chemokine CCL5; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation, Neoplastic; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Pain Measurement; Pain Threshold; Peptide T; Receptors, CCR1; Xanthenes | 2014 |